130 related articles for article (PubMed ID: 16556532)
1. Chemical enhancers for the absorption of substances through the skin: Laurocapram and its derivatives.
López-Cervantes M; Márquez-Mejía E; Cázares-Delgadillo J; Quintanar-Guerrero D; Ganem-Quintanar A; Angeles-Anguiano E
Drug Dev Ind Pharm; 2006 Mar; 32(3):267-86. PubMed ID: 16556532
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of percutaneous absorption by laurocapram.
Ogiso T; Iwaki M; Bechako K; Tsutsumi Y
J Pharm Sci; 1992 Aug; 81(8):762-7. PubMed ID: 1328599
[TBL] [Abstract][Full Text] [Related]
3. Effect of topical laurocapram (Azone) on the in vitro percutaneous permeation of sodium lauryl sulfate using human skin.
Szolar-Platzer C; Patil S; Maibach HI
Acta Derm Venereol; 1996 May; 76(3):182-5. PubMed ID: 8800295
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of skin penetration-enhancing effect by laurocapram.
Sugibayashi K; Nakayama S; Seki T; Hosoya K; Morimoto Y
J Pharm Sci; 1992 Jan; 81(1):58-64. PubMed ID: 1619571
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of percutaneous absorption of esculetin: effect of chemical enhancers.
del Rio Sancho S; Serna Jiménez CE; Calatayud Pascual MA; Balaguer Fernández C; Femenía Font A; Castillo García E; Merino V; López Castellano A
Planta Med; 2013 Jan; 79(2):131-6. PubMed ID: 23250808
[TBL] [Abstract][Full Text] [Related]
6. Effects of four penetration enhancers on corneal permeability of drugs in vitro.
Tang-Liu DD; Richman JB; Weinkam RJ; Takruri H
J Pharm Sci; 1994 Jan; 83(1):85-90. PubMed ID: 8138917
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous penetration of fluorescein isothiocyanate-dextrans and the mechanism for enhancement effect of enhancers on the intercellular penetration.
Ogiso T; Paku T; Iwaki M; Tanino T
Biol Pharm Bull; 1995 Nov; 18(11):1566-71. PubMed ID: 8593481
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship of 1-alkyl- or 1-alkenylazacycloalkanone derivatives as percutaneous penetration enhancers.
Okamoto H; Hashida M; Sezaki H
J Pharm Sci; 1988 May; 77(5):418-24. PubMed ID: 3411465
[TBL] [Abstract][Full Text] [Related]
9. Visualization of the penetration modifying mechanism of laurocapram by Mass Spectrometry Imaging in buccal drug delivery.
Handler AM; Marxen E; Jacobsen J; Janfelt C
Eur J Pharm Sci; 2019 Jan; 127():276-281. PubMed ID: 30439495
[TBL] [Abstract][Full Text] [Related]
10. Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors.
Ogiso T; Iwaki M; Paku T
J Pharm Sci; 1995 Apr; 84(4):482-8. PubMed ID: 7629741
[TBL] [Abstract][Full Text] [Related]
11. Azone analogues: classification, design, and transdermal penetration principles.
Jampilek J; Brychtova K
Med Res Rev; 2012 Sep; 32(5):907-47. PubMed ID: 22886628
[TBL] [Abstract][Full Text] [Related]
12. Effect of PEG 400, ethanol and laurocapram (Azone) on the transport of testosterone through rat skin.
Singh J; Satyanarayana S; Singh S
Pharmazie; 1992 Dec; 47(12):948-9. PubMed ID: 1293619
[No Abstract] [Full Text] [Related]
13. Synthesis and evaluation of N-acetylprolinate esters - novel skin penetration enhancers.
Tenjarla SN; Kasina R; Puranajoti P; Omar MS; Harris WT
Int J Pharm; 1999 Dec; 192(2):147-58. PubMed ID: 10567746
[TBL] [Abstract][Full Text] [Related]
14. Effects of penetration enhancers on the in-vitro percutaneous absorption of progesterone.
Valenta C; Wedenig S
J Pharm Pharmacol; 1997 Oct; 49(10):955-9. PubMed ID: 9364402
[TBL] [Abstract][Full Text] [Related]
15. Enhancing effect of piperidone derivatives on the percutaneous absorption of indomethacin.
Quan DY; Higuchi RI; Takayama K; Higashiyama K; Nagai T
Drug Des Deliv; 1990 May; 6(1):61-71. PubMed ID: 2078287
[TBL] [Abstract][Full Text] [Related]
16. Model analysis of flux enhancement across hairless mouse skin induced by chemical permeation enhancers.
He N; Warner KS; Higuchi WI; Li SK
Int J Pharm; 2005 Jun; 297(1-2):9-21. PubMed ID: 15907593
[TBL] [Abstract][Full Text] [Related]
17. Penetration enhancers.
Williams AC; Barry BW
Adv Drug Deliv Rev; 2004 Mar; 56(5):603-18. PubMed ID: 15019749
[TBL] [Abstract][Full Text] [Related]
18. In vitro percutaneous absorption of arildone, a highly lipophilic drug, and the apparent no-effect of the penetration enhancer Azone in excised human skin.
Baker EJ; Hadgraft J
Pharm Res; 1995 Jul; 12(7):993-7. PubMed ID: 7494819
[TBL] [Abstract][Full Text] [Related]
19. Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin.
Bond JR; Barry BW
J Invest Dermatol; 1988 Jun; 90(6):810-3. PubMed ID: 3373011
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous penetration modifiers and formulation effects.
Kaushik D; Costache A; Michniak-Kohn B
Int J Pharm; 2010 Feb; 386(1-2):42-51. PubMed ID: 19900521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
